Erlotinib in Combination With Cetuximab

NCT00895362 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: Erlotinib
DRUG: Cetuximab

Sponsor

M.D. Anderson Cancer Center